Home › Dermatomyositis › Pennsylvania › Philadelphia
Dermatomyositis clinical trials in Philadelphia, PA
4 studies for Dermatomyositis are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingPhase 3
- Research Site, Philadelphia
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
RecruitingObservational study
- Hospital of the University of Pennsylvania, Philadelphia
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- Houston, TX5 studies
- Boston, MA5 studies
- New York City, NY5 studies
- Pittsburgh, PA5 studies
- Miami, FL4 studies
- Baltimore, MD4 studies
- Kansas City, KS3 studies
- Aurora, CO3 studies
- Jacksonville, FL3 studies
- Cleveland, OH3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.